✦ LIBER ✦

The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers

✍ Scribed by Antonia Martinetti; Leonardo Ferrari; Luigi Celio; Luigi Mariani; Rosalba Miceli; Nicoletta Zilembo; Maria Di Bartolomeo; Luisa Toffolatti; Paola Pozzi; Ettore Seregni; Emilio Bombardieri; Emilio Bajetta

Book ID: 117668077
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 112 KB
Volume: 75
Category: Article
ISSN: 0960-0760
DOI: 10.1016/s0960-0760(00)00138-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

691 - The LHRH analogue triptoreline (TA

691 - The LHRH analogue triptoreline (TAP) with or without the aromatase inhibitor formestane (4-OHA) in premenopausal advanced breast cancer: A study by the I.T.M.O. group

✍ L. Celio; A. Martinetti; L. Ferrari; R. Buzzoni; E. Bombardieri; N. Zilembo; L. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A randomised study to compare the effect

A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer

✍ W. Jonat; M. Kaufmann; R.W. Blamey; A. Howell; J.P. Collins; A. Coates; W. Eierm 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 587 KB